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This contribution reports the first direct and noninvasive observation of cerebral glucose 
in normal anesthetized rats ( n  = 16) using short-echo-time localized proton NMR spec- 
troscopy (2.35 T, STEAM, TR = 6000 ms, TE = 20 ms, 125 ~ l ) .  In addition to resonances 
from N-acetyl aspartate (NAA), glutamate, total creatine, cholines, taurine, and myo- 
inositol, all spectra exhibit strongly coupled resonances from glucose (3.43, 3.80 ppm) 
that are readily identifiable using model solutions. The observed level of cerebral glucose 
in fasted rats covered a range of 15-4096 of that of NAA giving absolute concentrations 
of I .  1-2.8 m M  when NAA is taken to be 7 mM. The arterial blood glucose concentration 
was 7.7 ? 0.8 mhf in the same group Of animals. 0 1991 Academic Press, Inc. 
INTRODUCTION 
Glucose plays a central role in the energy metabolism of the brain providing more 
than 90% of its fuel (1, 2). Deviations of the cerebral glucose concentration under 
hypoglycemic or hyperglycemic (e.g., diabetes mellitus) conditions have pronounced 
consequences of foremost importance to clinical medicine. Analytical determinations 
of glucose in brain parenchyma ( 3 , 4 )  require tissue destruction and are therefore only 
applicable to animals. Freeze-clamp techniques may also be subject to ischemic artifacts 
that develop in the time span between sacrifice of the animal and destruction of en- 
zymatic functions, e.g., glucose delivery by glycogenolysis and glucose consumption 
by anaerobic glycolysis. 
More recently, a noninvasive NMR approach has been reported ( 5 , 6 )  for measuring 
brain glucose levels by means of an indirect proton-observe carbon-edited NMR tech- 
nique in live animals. Unfortunately, the investigation requires the infusion of carbon- 
13-enriched glucose so that brain glucose levels are investigated in the presence of 
high plasma concentrations beyond physiological conditions. Here we report on the 
first direct observation of cerebral glucose levels in normal anesthetized rats using 
image-guided, localized proton NMR spectroscopy. Since proton NMR considerably 
simplifies the experimental setup as well as the absolute quantification of metabolite 
concentrations, this method is expected to facilitate further studies of glucose transport 
in the brain by correlating plasma levels with in vivo cerebral levels. 
MATERIALS AND METHODS 
All studies were carried out at 100 MHz using a Biospec system (Bruker, Karlsruhe, 
FRG) equipped with a 2.35-T 40-cm-bore horizontal magnet and an actively shielded 
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gradient system (Oxford Instruments, Oxford, UK) . Homogeneous radiofrequency 
(rf) excitation was performed using a homebuilt 12-cm Helmholz coil with signal 
reception by a 2-cm-diameter loop coaxial transmission line resonator. All modifi- 
cations of the standard Bruker hardware configuration have been previously described 
( 7). Localized proton NMR spectra were obtained with the use of a STEAM sequence 
employing three chemical-shift-selective (CHESS) rf pulses for water suppression: 
[CHESS-Spoil],-9O0 (x)-TE/2-9O0 (y)-TM-9Oo (z)-TE/2-Acq. 
In order to minimize T2 relaxation losses and to avoid spectral complications due 
to complex J modulation, the echo time was set to TE = 20 ms (TM = 30 ms) in all 
cases. Fully relaxed proton NMR spectra were acquired from a 5 X 5 X 5-mm3 ( 125-pl) 
volume-of-interest (VOI) positioned centrally in the brain. Water suppression resulted 
in a ratio of residual water/N-acetyl aspartate( NAA) in the range 2-10, thus avoiding 
baseline artifacts in the spectra. Data processing consisted of zero filling to 8K complex 
points, 2.0 Hz Gaussian multiplication in the time domain, and Fourier transformation 
followed by zero- and first-order phase correction. Measuring times of individual spectra 
were 6.4 and 12.8 min using 128 scans and repetition times of TR = 3000 and 6000 
ms, respectively. 
The study included 14 Wistar albino rats (350-500 g body wt) and 2 Sprague- 
Dawley rats ( 180-200 g body wt). Moreover, glucose resonances were frequently 
observed in other rats ( n  m 70) investigated in this lab. The animals were anesthetized 
using intraperitonial chloralhydrate (360 mg/kg body wt) and placed in a prone po- 
sition with the receiver coil positioned over the head without surgery. More recently, 
halothane anesthesia ( 1.0% in 7:3 N20:02) has been employed. No change in the 
detectability of glucose was observed. Arterial plasma glucose levels were determined 
enzymatically ( 8 ) . 
RESULTS 
The assignment of the strongly coupled resonances of glucose at a field strength of 
2.0 T as well as their observation in localized proton NMR spectra of gray matter in 
human diabetics has been reported in preceding papers (9 ,  10). The appearance of 
the respective resonances at a field strength of 2.35 T is demonstrated in Fig. 1. It 
demonstrates the influence of strong coupling at the lower field strength which effec- 
tively simplifies the multiplet structure observed at 7.0 T. Following line broadening 
to mimic the in vivo linewidths of 6-7 Hz in proton NMR spectra of rat brain at 2.35 
T, three prominent resonances remain at 3.43, 3.80, and 3.86 ppm. In Fig. Id glucose 
is best appreciated by its 3.43 ppm resonance even though it overlaps the outermost 
up-field resonance of taurine (see below). Depending on the glucose concentration 
the other two resonances contribute to a shoulder on the 3.75 ppm CH resonance of 
glutamate. 
Localized proton NMR spectra of model solutions with different concentrations of 
glucose are shown in Fig. 2. The model solutions contain mixtures of cerebral metab- 
olites with relative concentrations that resemble the spectral pattern observed in rat 
brain in vivo: 12 m M  NAA and glutamate, 10 m M  creatine, 2 m M  choline, 3 m M  
taurine, and 8 m M  myo-inositol. The known ratios and the resulting spectral patterns 
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FIG. 1. Proton NMR spectra of an aqueous solution of glucose at ( a )  7.0 T and (b,c) 2.35 T in comparison 
to (d )  a 2.35-T proton NMR spectrum of rat brain in vivo. ( a )  Fully relaxed FID spectrum of glucose (7.0 
T, pH 7.2,50 mM, *acetate reference at I .9 15 ppm); (b) fully relaxed, localized proton spectrum of glucose 
(2.35 T, STEAM, 125-gl VOI, TE = 20 ms, pH 7.2, 50 m M  in a 10-ml spherical flask, *reference); (c) 
line-broadened version of spectrum (b )  yielding major resonances at 3.43, 3.80, and 3.86 ppm; and (d) 
localized proton NMR spectrum of rat brain in vivo (2.35 T, STEAM, I25-pl VOI, TE = 20 ms, TR = 3000 
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FIG. 2. Localized proton NMR spectra of metabolite model solutions (2.35 T, STEAM, 125-pl VOI, TR 
= 6000 ms, TE = 20 ms, TM = 30 ms, 64 scans, 6.4 min, pH 7.1) comprising 10 mMcreatine (Cr), 12 
mMN-acetyl aspartate (NAA), 12 mMglutamate (Glu), 2 mMcholine (Cho), 3 m M  taurine (Tau), and 
8 m M  myo-inositol (Ins). The spectra represent the metabolic pattern of normal rat brain for three different 
concentrations of glucose and are significantly line-broadened to mimic the in vivo resolution. (a) 6 m M  
glucose (50% of NAA), (b) 2 mM glucose ( 17% of NAA), and ( c )  no glucose. 
FIG. 3. Localized proton NMR spectra of rat brain in vivo (2.35 T, STEAM, TR = 6000 ms, TE = 20 
ms, TM = 30 ms, 128 scans, 12.8 min, 2 Hz line broadening) acquired from a centrally located 125-pl VO1 
as shown in Fig. I .  The spectra originate from three different animals and represent the range of glucose 
levels observed in this study. Resonances are due to N-acetyl aspartate (NAA), glutamate (Glu), phospho- 
creatine and creatine (PCr/Cr), cholines (Cho), taurine (Tau), myo-inositol (Ins), and glucose. 
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In Fig. 2 the glucose concentration is zero in the bottom spectrum (c), 2 m M  in the 
middle spectrum (b) , and 6 m M  in the top spectrum (a). This corresponds to 17 and 
50% of the NAA concentration for spectra (b) and (a),  respectively. 
Figure 3 shows in vivo brain spectra obtained from three different rats. The spectra 
cover the range of glucose signal intensities observed in this study. In general, the 
interindividual reproducibility of the metabolite resonances is excellent. Resonance 
assignments follow the data presented in Fig. 2 as well as a previous study on proton 
NMR spectroscopy of rat brain in vivo at 2.35 T (7). Minor signal variations were 
observed for choline-containing compounds, whereas the glucose intensity shows a 
certain degree of variability. The relative brain tissue concentrations of glucose are 
summarized in Table 1 and compared to the mean arterial blood glucose level deter- 
mined for the same group of animals. Cerebral glucose levels are given in units of the 
NAA and total creatine concentrations relative to the model solutions shown in Fig. 
2. Absolute concentrations are discussed below. 
To further confirm the NMR assignment of glucose resonances, Fig. 4 shows the 
metabolic alterations obtained for two rats before and 25 min after death. Sacrifice of 
the animals was accomplished by intraperitoneal potassium cyanide. While the in vivo 
spectra show glucose resonances within the range described by Fig. 3, the postmortem 
spectra exhibit no detectable glucose signals but strongly elevated levels of lactate. 
Assuming a 7 m M  concentration of NAA (see below), the accumulation of about 20 
m M  lactate originates from continued glycogenolysis and anaerobic glycolysis. De- 
pletion of the steady-state level of cerebral glucose removes spectral contributions at 
3.43, 3.80, and 3.86 ppm and allows three out of four strongly coupled resonances of 
taurine (3.26, 3.32, 3.38, and 3.43 ppm) to be resolved. The overall reduction in peak 
amplitudes postmortem is due to a slightly poorer magnetic field homogeneity leading 
to line broadening. 
DISCUSSION 
The feasibility of direct and noninvasive observation of glucose in localized proton 
NMR spectra of rat brain in vivo provides a unique means for monitoring glucose 
concentration in tissues. For this purpose the identification of glucose resonances must 
be followed by a quantification of cerebral concentrations. The relative concentration 
TABLE 1 
Concentrations of Arterial Plasma Glucose and Brain Glucose in Normal 
24-h-Fasted Rats ( n  = 14) as Determined by Enzymatic Blood Analysis 
and Proton NMR Spectroscopy in Vivo, Respectively 
Brain 
Plasma (mM) 70 [PCr/Cr] 9% [NAA] mM" 
7.7 2 0.8 20-50 15-40 1.1-2.8 
a Absolute concentrations of cerebral glucose are based on the assumption 
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FIG. 4. Localized proton NMR spectra of rat brain before and 25 min after death (2.35 T, STEAM, TR 
= 3000 ms, TE = 20 ms, TM = 30 ms, 128 scans, 6.4 min, 2 Hz line broadening). The spectra in (a)  and 
(b)  originate from two different animals. The postmortem spectra show elevated levels of lactate (Lac), a 
depletion of glucose, and a concomitant resolution of three out of four taurine (Tau) resonances (3.26, 
3.32, 3.38, and 3.43 ppm). Magnetic field homogeneity is compromised in the postmortem spectra. 
of glucose was estimated by comparing the in vivo spectra with those of model solutions 
with various glucose concentrations (e.g., see Fig. 2). The results are given in Ta- 
ble 1. 
Absolute concentrations require an internal reference. For example, the total creatine 
concentration is generally assumed to be 10 m M  ( I  1 ) which would result in cerebral 
glucose concentrations of 2.0-5.0 mM. However, the creatine data from tissue extracts 
contradict our recent findings in human brain in vivo . Following three different strat- 
egies for absolute quantification (water reference, external phantom, separate phantom 
studies) the NAA concentration turns out to be about 10 mM, yielding a total creatine 
concentration of only 5-6 m M  (12). Assuming the same creatine concentration in 
rat brain, the NAA concentration will be 7 m M  in agreement with a large number of 
biochemical determinations ( 13).  
Assuming a 7 m M  NAA concentration the cerebral glucose is in the range 1.1 to 
2.8 m M  as indicated in the last column of Table 1. This value corresponds to a ratio 
of brain glucose to arterial blood glucose in anesthetized rats of 0.26 as opposed to 
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0.45 if 10 m M  creatine is assumed. More detailed insights into glucose transport 
require certainty about the determination of absolute metabolite concentrations by 
proton NMR and will be pursued in subsequent glucose clamp studies. Moreover, the 
known effects of anesthesia on blood and brain glucose levels (2) will be the subject 
of further investigations. 
Obviously, the relative cerebral glucose concentration in rats is higher than that in 
human brain. In a very large number of proton NMR studies of human volunteers, 
we have never observed glucose resonances under normoglycemia. This finding limits 
the human brain glucose concentration to a value below the level of detectability, i.e., 
to < 1 m M  (or 10% of the NAA concentration). Using an arterial glucose value of 
4.5 mM, also the human brain/blood glucose ratio of <0.22 is lower than that 
in rats. 
ACKNOWLEDGMENTS 
Financial support by the Bundesminister fur Forschung und Technologie (BMlT) of the Federal Republic 
of Germany (Grant 0 1 VF 8606 /6)  is gratefully acknowledged. We thank Sigrid Nickel and Michaela Beul3e 
for technical assistance. 
REFERENCES 
1. H. LUND-ANDERSEN, Physiol. Rev. 59, 305 ( 1979). 
2. H. S. BACHELARD, in “Handbook of Neurochemistry” (A. Lajtha, Ed.), Vol. 5, p. 399, Plenum, New 
3. L. D. LEWIS, B. LJUNGGREN, K. NORBERG, AND B. K. SIESJO, J. Neurochern. 23,659 ( 1974). 
4. H. KINOUCHI, S. IMAIZUMI, T. YOSHIMOTO, AND M. MOTOMIYA, Stroke 21, 1326 (1990). 
5. S. M. FITZPATRICK, H. P. HETHERINGTON, K. L. BEHAR, AND R. G. SHULMAN, J. Cereb. Blood Flow 
Mefab. 10, 170 (1990). 
6. G. F. MASON, K. L. BEHAR, D. A. BOEHM, AND R. G. SHULMAN, tn “Proceedings, 9th Annual Meeting 
of the Society of Magnetic Resonance in Medicine, August 18-24, 1990, New York,” p. 69. 
7. M. L. GYNGELL, J. ELLERMANN, T. MICHAELIS, W. HANICKE, K. D. MERBOLDT, H. BRUHN, AND J. 
FRAHM, NMR Biomed. 5, ( 199 1 ). 
8. 0. H. LOWRY AND J. V. PASSONNEAU, “A Flexible System of Enzymatic Analysis,” Academic Press, 
New York, 1972. 
9. T. MICHAELIS, K. D. MERBOLDT, W. HANICKE, M. L. GYNGELL, H. BRUHN, AND J. FRAHM, NMR 
Biomed. 5, ( 199 1 ) . 
337,745 (1991). 
York, 1983. 
10. H. BRUHN, T. MICHAELIS, K. D. MERBOLDT, W. HANICKE, M. L. GYNGELL, AND J. FRAHM, Lancet 
11. L. D. LEWIS, B. LJUNGGREN, R. A. RATCHESON, AND B. K. SIESJO, J. Neurochem. 23,673 (1974). 
12. T. MICHAELIS, H. BRUHN, M. L. GYNGELL, W. HANICKE, AND J. FRAHM, in “Proceedings, 10th 
Annual Meeting of the Society of Magnetic Resonance in Medicine, August 12-16, 1991, San Fran- 
cisco.” 
13. D. L. BIRKEN AND W. H. OLDENDORF, Neurosci. Biobehav. Rev. 13,23 ( 1989). 
